Q301--New Long-Term Renal/Kidney Fy25 08/01/2025 - 07/31/2030 Donor-Derived Cell-Free Dna Tests.

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 106356643

  Document Type - Tender Notices

Description - Description: The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department performs kidney transplants for the Western Region. Donor-derived cell-free DNA (dd-cfDNA) is a blood tests that is non-invasive for kidney transplant surveillance. The importance of the surveillance is to monitor for rejections. Rejection can lead to damage and injury to the transplanted kidney. Other benefits of the blood tests include decreasing the necessity for invasive biopsy of the transplanted kidney and subsequent turn-around-time (TAT) of the biopsy results. The blood test can be drawn at any phlebotomy site without the necessity to schedule for Interventional Radiology to

Gt Ref Id - 106356643

Deadline - Apr 18, 2025